Thalassemia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Thalassemia}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Thalassemia]]
{{CMG}} {{shyam}}
{{CMG}}; {{AE}}{{shyam}}
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
 


==Overview==
==Overview==
 
A variety of diseases can mimic thalassemia. These include sickle cell anemia, iron-deficiency anemia, hemolytic anemia, sideroblastic anemia, anemia of chronic disease, vitamin B12 deficiency, and erythropoietin deficiency. It is important to distinguish amongst these conditions, as each condition has different clinical consequences and treatment considerations.
==Differential Diagnosis==
==Differential Diagnosis==


Line 24: Line 24:
* [[Microcytic]] (<80 femtoliter) in most cases
* [[Microcytic]] (<80 femtoliter) in most cases
|
|
* Abnormal [[hemoglobin]] [[electrophoresis]] (in [[beta-thalassemia]])
* Abnormal [[hemoglobin]] [[electrophoresis]]
* Normal [[hemoglobin]] [[electrophoresis]] (in [[alpha-thalassemia]])
* Abnormal [[high performance liquid chromatography]]<ref name="pmid16461765">{{cite journal| author=Chui DH, Cunningham MJ, Luo HY, Wolfe LC, Neufeld EJ, Steinberg MH| title=Screening and counseling for thalassemia. | journal=Blood | year= 2006 | volume= 107 | issue= 4 | pages= 1735-7 | pmid=16461765 | doi=10.1182/blood-2005-09-3557 | pmc=1895412 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16461765  }} </ref>
* Elevated ferritin (due to frequent transfusions and iron overload)
* Elevated ferritin (due to frequent transfusions and iron overload)
* Microcytic hypochromic anemia
|
|
* [[Irritability]]  
* [[Irritability]]  
Line 40: Line 41:
|
|
* [[Extramedullary hematopoiesis]]
* [[Extramedullary hematopoiesis]]
* [[Mental retardation]]<ref name="pmid23028133">{{cite journal| author=Gibbons RJ| title=α-Thalassemia, mental retardation, and myelodysplastic syndrome. | journal=Cold Spring Harb Perspect Med | year= 2012 | volume= 2 | issue= 10 | pages=  | pmid=23028133 | doi=10.1101/cshperspect.a011759 | pmc=3475406 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23028133  }} </ref>
* [[Myelodysplastic syndrome]]<ref name="pmid23028133">{{cite journal| author=Gibbons RJ| title=α-Thalassemia, mental retardation, and myelodysplastic syndrome. | journal=Cold Spring Harb Perspect Med | year= 2012 | volume= 2 | issue= 10 | pages=  | pmid=23028133 | doi=10.1101/cshperspect.a011759 | pmc=3475406 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23028133  }} </ref>
|-
|-
||[[Sickle cell anemia]]   
||[[Sickle cell anemia]]   
Line 51: Line 54:
* Sickled [red blood cells]] on peripheral blood smear
* Sickled [red blood cells]] on peripheral blood smear
* Elevated ferritin (due to frequent transfusions and iron overload)
* Elevated ferritin (due to frequent transfusions and iron overload)
* Elevated [[red blood cell]] mass
|
|
* Vaso-occlusion in peripheral vascular beds
* Vaso-occlusion in peripheral vascular beds
Line 213: Line 217:
* [[Neuropathy]]
* [[Neuropathy]]
|}
|}


==References==
==References==

Latest revision as of 20:30, 27 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shyam Patel [2]


Overview

A variety of diseases can mimic thalassemia. These include sickle cell anemia, iron-deficiency anemia, hemolytic anemia, sideroblastic anemia, anemia of chronic disease, vitamin B12 deficiency, and erythropoietin deficiency. It is important to distinguish amongst these conditions, as each condition has different clinical consequences and treatment considerations.

Differential Diagnosis

Characteristic/Parameter Etiology Mean corpuscular volume Laboratory abnormalities Physical examination Treatment Other associated abnormalities
Thalassemia
Sickle cell anemia
  • Genetic defect resulting in sickled hemoglobin
  • Point mutation in beta-globin chain, converting glutamic acid to valine
  • Abnormal hemoglobin electrophoresis with elevated HbSS fraction
  • Sickled [red blood cells]] on peripheral blood smear
  • Elevated ferritin (due to frequent transfusions and iron overload)
  • Elevated red blood cell mass
  • Folate supplemention
  • Hydroxyurea (to increase fetal hemoglobin production
  • Oxygen supplemention
  • Transfusion support
  • Iron chelation
  • Gene therapy if available
  • Crizanlizumab (P-selectin inhibitor)
  • Patient education and genetic counseling
Iron deficiency anemia
  • Intravenous or oral iron supplementation
  • Blood transfusions
Hemolytic anemia
Sideroblastic anemia

Or

Anemia of chronic disease
Erythropoietin deficiency
  • Epoetin alfa 50-100 units/kg 3 times weekly
  • Darbepoietin 0.45 mcg/kg weekly or 0.75 mcg/kg every 2 weeks[3]
Vitamin B12 or folate deficiency

References

  1. Chui DH, Cunningham MJ, Luo HY, Wolfe LC, Neufeld EJ, Steinberg MH (2006). "Screening and counseling for thalassemia". Blood. 107 (4): 1735–7. doi:10.1182/blood-2005-09-3557. PMC 1895412. PMID 16461765.
  2. 2.0 2.1 Gibbons RJ (2012). "α-Thalassemia, mental retardation, and myelodysplastic syndrome". Cold Spring Harb Perspect Med. 2 (10). doi:10.1101/cshperspect.a011759. PMC 3475406. PMID 23028133.
  3. Platzbecker U, Symeonidis A, Oliva EN, Goede JS, Delforge M, Mayer J; et al. (2017). "A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes". Leukemia. 31 (9): 1944–1950. doi:10.1038/leu.2017.192. PMC 5596208. PMID 28626220.

Template:WH Template:WS